| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1055-3207(02)00003-0 |
| P698 | PubMed publication ID | 12424849 |
| P2093 | author name string | Rhonda F Souza | |
| P2860 | cites work | A Restriction Point for Control of Normal Animal Cell Proliferation | Q24620882 |
| Evolution of neoplastic cell lineages in Barrett oesophagus | Q24676889 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
| The complexity of p53 modulation: emerging patterns from divergent signals | Q28284854 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression | Q28344807 | ||
| Cancer cell cycles | Q29547756 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa | Q30307786 | ||
| Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma | Q33642981 | ||
| Control of the cell cycle and apoptosis | Q33735440 | ||
| Identification of a phorbol ester-repressible v-src-inducible gene | Q33837057 | ||
| Molecular biology of esophageal squamous cell carcinoma | Q33875652 | ||
| A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor | Q34661010 | ||
| Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma | Q36228101 | ||
| Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma | Q36620193 | ||
| TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe | Q36623678 | ||
| Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations | Q37245090 | ||
| 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus | Q37487038 | ||
| Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction | Q37527489 | ||
| HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma | Q40779159 | ||
| Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review | Q41017427 | ||
| The role of FasL-induced apoptosis in immune privilege | Q41472346 | ||
| The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions | Q41554100 | ||
| Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha | Q41579755 | ||
| The host-tumor immune conflict: from immunosuppression to resistance and destruction | Q41633001 | ||
| Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure | Q41723021 | ||
| Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium | Q42808304 | ||
| Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus | Q43221529 | ||
| Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers | Q43588831 | ||
| Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas | Q43873709 | ||
| Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma | Q43891550 | ||
| Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma | Q45073181 | ||
| Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer | Q45141950 | ||
| Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. | Q50958133 | ||
| Cancer statistics, 1997. | Q50980276 | ||
| Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. | Q52183100 | ||
| Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus. | Q53401885 | ||
| Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. | Q53426683 | ||
| Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. | Q53460669 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables | Q58105169 | ||
| Abnormal expression of growth regulatory factors in Barrett's oesophagus | Q58105505 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus | Q58409008 | ||
| Barrett's esophagus | Q69885120 | ||
| Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 | Q70787131 | ||
| Fas ligand and immune evasion | Q71840940 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification | Q72078811 | ||
| p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia | Q72463048 | ||
| p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study | Q72638571 | ||
| Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy | Q72691179 | ||
| Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach | Q73006584 | ||
| Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus | Q73265604 | ||
| Fas ligand expression in esophageal carcinomas and their lymph node metastases | Q73388418 | ||
| Loss of heterozygosity on chromosome 9 andp16 (MTS1, CDKN2) gene mutations in esophageal cancers | Q73486608 | ||
| Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population | Q73790393 | ||
| Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus | Q73814884 | ||
| Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma | Q74082558 | ||
| C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions | Q77507536 | ||
| Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus | Q77620687 | ||
| Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations | Q77780251 | ||
| Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities | Q78167068 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 257-72, viii | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Surgical oncology clinics of North America | Q25379760 |
| P1476 | title | Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma | |
| P478 | volume | 11 |
| Q38601588 | Activation of NADPH oxidases leads to DNA damage in esophageal cells |
| Q34813865 | Anthocyanins in black raspberries prevent esophageal tumors in rats. |
| Q41855195 | Berry ellagitannins may not be sufficient for prevention of tumors in the rodent esophagus. |
| Q36809345 | Chemoprevention of esophageal squamous cell carcinoma |
| Q34505404 | Comprehensive spectral endoscopy of topically applied SERS nanoparticles in the rat esophagus |
| Q41815580 | Cytokines and growth factors expressed by human cutaneous melanoma |
| Q38758937 | Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats |
| Q43022841 | Immunohistochemical expression of P53 and Ki-67 in diethylnitrosamine-induced carcinomas esophageal: experimental model |
| Q36159826 | In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles |
| Q53288332 | Mechanistic basis for the chemopreventive effects of black raspberries at a late stage of rat esophageal carcinogenesis. |
| Q42510390 | Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells |
| Q38956080 | Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis. |
| Q34326627 | Pathogenetic mechanisms in gastric cancer |
| Q35770045 | Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study |
| Q37368400 | Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus |
| Q34758867 | Squamous cell cancer of the esophagus: the forgotten one. |
| Q35609586 | p73 protein regulates DNA damage repair |
Search more.